Cyclerion Therapeutics (CYCN) Other Operating Expenses (2019 - 2025)

Cyclerion Therapeutics (CYCN) recorded quarterly Other Operating Expenses of $1.3 million in Q2 2025, down 60.65% quarter-over-quarter from $3.3 million in Q3 2023.

Cyclerion Therapeutics (CYCN) Other Operating Expenses (2019 - 2025) Analysis & Trends

Cyclerion Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $1.3 million for Q2 2025.

  • In Q2 2025, Other Operating Expenses changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (changed N/A YoY), while the FY2023 annual figure was $3.3 million, changed N/A from the prior year.
  • Other Operating Expenses was $1.3 million for Q2 2025 at Cyclerion Therapeutics, down from $3.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $3.3 million in Q3 2023 to a low of -$881000.0 in Q2 2021.
  • Historically, Other Operating Expenses has averaged $1.2 million across 3 years, with a median of $1.3 million in 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Cyclerion Therapeutics 11.50 Mn 8.26 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.30 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2021 -881,000.00
Sep 30, 2020 444,000.00
Mar 31, 2020 -2.11 Mn
Dec 31, 2019 -27.87 Mn